Dr. Mohile completed his residency training at Northwestern University, followed by a fellowship in Neuro-oncology at Memorial Sloan-Kettering Cancer Center. He is certified in Neurology and Neuro-oncology. In 2007, he joined the neurology department at the University of Rochester where he built and fostered the neuro-oncology division and multi-disciplinary brain tumor program. His mission is to teach, elevate clinical care and perform research that extends and improves the lives of patients with brain tumors.

Dr. Mohile sees patients with primary and metastatic brain tumors and is involved in administering chemotherapy, treating seizures and managing side effects of brain tumors and brain tumor therapy. In addition, he does consultations on patients with neurologic complications of cancer or cancer treatments.

Certified Specialties

Neurology - American Board of Psychiatry & Neurology

Faculty Appointments

Professor - Department of Neurology, Neuro-Oncology (SMD)

Ann Aresty Camhi Professorship in Neurology - Department of Neurology, Neuro-Oncology (SMD)

Professor - Cancer Center - Joint

Credentials

Residency & Fellowship

Fellowship, Memorial Sloan-Kettering Cancer Center. 2005 - 2007

Fellowship, Clinical Neurophysiology, Northwestern Memorial Hospital. 2004 - 2005

Residency, Neurology, Northwestern Memorial Hospital. 2001 - 2004

Internship, Internal Medicine, Norwalk Hospital. 2000 - 2001

Education

MD | St. George's University School of Medicine (Grenada). 2000

Awards

A. B. Baker Teacher Recognition Award. 2015

Neurology Faculty Teaching Award. 2011

SWOG Travel Award Recipient. 2011

American Neurological Association Junior Academic Scholarship Award. 2009

American Society of Clinical Oncology Foundation Merit Award. 2007

Graduate Medical Education Award for excellence in teaching medical students. 2004

AAN Resident Annual Meeting Scholarship. 2004

Dean's List. 1996 - 2000

Dean's List. 1994

Research

His research focuses on developing and testing therapeutic and supportive care interventions to improve and extend the lives of patients with malignant gliomas. He has authored over 50 peer-reviewed publications. He is currently the principal investigator of several industry-sponsored, investigator-initiated and NCI- funded clinical trials. He has developed a body of work that explores the burdens experienced by patients with brain tumors and caregivers, related to hospitalizations, seizures, decision-making and end of life care.

Clinical Trials

Early Telehealth Visits for Discussion of Advanced Directives for Patients Newly Diagnosed With High Grade Glioma: Impact on Patient Care and Satisfaction

Lead Researcher: Nimish A Mohile

High grade gliomas (HGGs) are rapidly progressive brain tumors resulting in death for most patients between 6 months and 2 years after diagnosis. It is important for patients with HGG to discuss and document their wishes at the end of life. However, ...

Genomically-Guided Treatment Trial in Brain Metastases

Lead Researcher: Nimish A Mohile

This phase II trial studies how well genetic testing works in guiding treatment for patients with solid tumors that have spread to the brain. Several genes have been found to be altered or mutated in brain metastases such as NTRK, ROS1, CDK, PI3K, or...

Publications

Journal Articles

Advancing LGBTQI+ Equity in Neurology: An AAN Position Statement.

Rosendale N, L'Erario ZP, Ekholm D, Deeb W, Zeigler G, Harrington CA, Benson RT, Mohile NA, Hamilton RH, Hinson HE,

Neurology.. 2025 January 14104 (1):e210119. Epub 12/10/2024.

Understanding Diversity, Equity, and Inclusion Roles in Academic Neurology Departments.

Spector AR, Mohile NA, Chadehumbe M, Croff R, Flippen Ii CC, Gutierrez CA, Hamilton RH, Leacock R, Monteith TS, O'Carroll C, Rutatangwa A, Thomas RP

Neurology.. 2024 November 26103 (10):e209989. Epub 10/23/2024.

Efficacy of trastuzumab deruxtecan in treating HER2-low breast cancer leptomeningeal metastasis: a case report.

Kharel Z, Stanford S, Hemminger LE, Schmidt T, Hardy SJ, Zittel J, Mohile NA, Dhakal A

Personalized medicine.. 2024 November 20 :1-5. Epub 11/20/2024.

Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial.

Sarkaria JN, Ballman KV, Kizilbash SH, Sulman EP, Giannini C, Friday BB, Butowski NA, Mohile NA, Piccioni DE, Battiste JD, Drappatz J, Campian JL, Mashru S, Jaeckle KA, O'Brien BJ, Dixon JG, Kabat BF, Laack NL, Hu LS, Kaufmann T, Kumthekar P, Ellingson BM, Anderson SK, Galanis E

JAMA oncology.. 2024 October 31 Epub 10/31/2024.

Effect of Breast Cancer Receptor Subtypes and CSF Cytology Status on Survival of Patients With Leptomeningeal Disease.

Niraula S, Gouli S, Baran AM, O'Regan R, Tyburski H, Zhang H, Hardy S, Mohile N, Anders CK, Dhakal A

Clinical breast cancer.. 2024 October 5 Epub 10/05/2024.

Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system.

Kleckner IR, Manuweera T, Lin PJ, Chung KH, Kleckner AS, Gewandter JS, Culakova E, Tivarus ME, Dunne RF, Loh KP, Mohile NA, Kesler SR, Mustian KM

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2024 September 2132 (10):677. Epub 09/21/2024.

Impact of systemic disease on CNS disease control after stereotactic radiosurgery to breast cancer brain metastases (The SYBRA Study).

Schick A, Hardy S, Strawderman M, Zheng D, Cummings M, Milano MT, Magnuson A, Behr J, Sammons S, Usuki K, Mohile N, O'Regan R, Anders CK, Hicks D, Dhakal A

NPJ breast cancer.. 2024 August 210 (1):69. Epub 08/02/2024.

Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101.

Batchelor TT, Giri S, Ruppert AS, Geyer S, Smith SE, Mohile N, Swinnen LJ, Friedberg JW, Kahl BS, Bartlett NL, Hsi ED, Cheson BD, Wagner-Johnston ND, Nayak L, Leonard JP, Rubenstein JL

Blood advances.. 2024 June 258 (12):3189-3199. Epub 1900 01 01.

Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients.

Ranjan S, Leung D, Ghiaseddin AP, Taylor JW, Lobbous M, Dhawan A, Budhu JA, Coffee E, Melnick K, Chowdhary SA, Lu-Emerson C, Kurz SC, Burke JE, Lam K, Patel MP, Dunbar EM, Mohile NA, Peters KB

Cancer.. 2024 May 1130 (9):1577-1589. Epub 01/30/2024.

Wireless Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Proof-of-Concept Randomized Clinical Trial.

Gewandter JS, Culakova E, Davis JN, Gada U, Guido JJ, Bearden JD, Burnette B, Shah D, Morrow G, Mustian K, Sluka K, Mohile N

The journal of pain.. 2024 May 25 (5):104431. Epub 11/21/2023.

Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system.

Kleckner IR, Manuweera T, Lin PJ, Chung KH, Kleckner AS, Gewandter JS, Culakova E, Tivarus ME, Dunne RF, Loh KP, Mohile NA, Kesler SR, Mustian KM

Research square.. 2024 March 13 Epub 03/13/2024.

Management of Paraneoplastic Syndromes in the Era of Immune Checkpoint Inhibitors.

Jean MJ, Samkoff L, Mohile N

Current treatment options in oncology.. 2024 January 25 (1):42-65. Epub 01/10/2024.

Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma.

Goldlust SA, Nabors LB, Hsu S, Mohile N, Duic PJ, Benkers T, Singer S, Rao M, Cappello L, Silberman SL, Farmer G

Neuro-oncology advances.. 2024 6 (1):vdae009. Epub 01/18/2024.

Diversity, Equity, Inclusion, and Health Inequities Training in Neurologic Disorders and Stroke: Analysis and Recommendations From the NINDS Advisory Council Working Group.

Brody DL, Gottesman RF, Griffin G, Khaliq ZM, Lackland DT, Ling G, Mohile N

Neurology.. 2023 August 15101 (7 Suppl 1):S59-S66. Epub 1900 01 01.

Resident-Centered Outcomes in Subspecialty Neurology Education.

Mohile N

Neurology. Education.. 2023 June 2 (2):e200080. Epub 05/26/2023.

Cognitive and neuroimaging outcomes in individuals with benign and low-grade brain tumours receiving radiotherapy: a protocol for a prospective cohort study.

Hardy SJ, Finkelstein AJ, Tivarus M, Culakova E, Mohile N, Weber M, Lin E, Zhong J, Usuki K, Schifitto G, Milano M, Janelsins-Benton MC

BMJ open.. 2023 February 1513 (2):e066458. Epub 02/15/2023.

Stroke death in patients receiving radiation for head and neck cancer in the modern era.

Hardy SJ, Bandyopadhyay S, Yang H, Williams A, Gudina A, Cummings MA, Zhang H, Singh DP, Chen Y, Mohile NA, Janelsins MC, Milano MT

Frontiers in oncology.. 2023 13 :1111764. Epub 06/15/2023.

Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline.

Schiff D, Messersmith H, Brastianos PK, Brown PD, Burri S, Dunn IF, Gaspar LE, Gondi V, Jordan JT, Maues J, Mohile N, Redjal N, Stevens GHJ, Sulman EP, van den Bent M, Wallace HJ, Zadeh G, Vogelbaum MA

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2022 July 1040 (20):2271-2276. Epub 05/13/2022.

Practical guidance for telemedicine use in neuro-oncology.

Strowd RE, Dunbar EM, Gan HK, Kurz S, Jordan JT, Mandel JJ, Mohile NA, Nevel KS, Taylor JW, Ullrich NJ, Welch MR, Wasilewski A, Mrugala MM

Neuro-oncology practice.. 2022 April 9 (2):91-104. Epub 01/17/2022.

Mechanisms, Mediators, and Moderators of the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy.

Chung KH, Park SB, Streckmann F, Wiskemann J, Mohile N, Kleckner AS, Colloca L, Dorsey SG, Kleckner IR

Cancers.. 2022 February 2614 (5)Epub 02/26/2022.

Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.

Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff D

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2022 February 1040 (5):492-516. Epub 12/21/2021.

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline.

Mohile NA, Messersmith H, Gatson NT, Hottinger AF, Lassman A, Morton J, Ney D, Nghiemphu PL, Olar A, Olson J, Perry J, Portnow J, Schiff D, Shannon A, Shih HA, Strowd R, van den Bent M, Ziu M, Blakeley J

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2022 February 140 (4):403-426. Epub 12/13/2021.

Tele-neuro-oncology: Current Practices and Future Directions.

Wasilewski A, Mohile N

Current oncology reports.. 2022 January 24 (1):99-103. Epub 01/20/2022.

Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial.

Griguer CE, Oliva CR, Coffey CS, Cudkowicz ME, Conwit RA, Gudjonsdottir AL, Ecklund DJ, Fedler JK, Neill-Hudson TM, Nabors LB, Benge M, Hackney JR, Chase M, Leonard TP, Patel T, Colman H, de la Fuente M, Chaudhary R, Marder K, Kreisl T, Mohile N, Chheda MG, McNeill K, Kumthekar P, Dogan A, Drappatz J, Puduvalli V, Kowalska A, Graber J, Gerstner E, Clark S, Salacz M, Markert J

Neuro-oncology advances.. 2022 4 (1):vdab186. Epub 12/24/2021.

Contemporary Neuroscience Core Curriculum for Medical Schools.

Gelb DJ, Kraakevik J, Safdieh JE, Agarwal S, Odia Y, Govindarajan R, Quick A, Soni M, , Bickel J, Gamaldo C, Hannon P, Hatch HAM, Hernandez C, Merlin LR, Noble JM, Reyes-Iglesias Y, Marie E Salas R, Sandness DJ, Treat L, , Benameur K, Brown RD, DeLuca GC, Garg N, Goldstein LB, Gutmann L, Henchcliffe C, Hessler A, Jordan JT, Kilgore SM, Khan J, Levin KH, Mohile NA, Nevel KS, Roberts K, Said RR, Simpson EP, Sirven JI, Smith AG, Southerland AM, Wilson RB

Neurology.. 2021 October 497 (14):675-684. Epub 10/04/2021.

Caregiving burden of informal caregivers of older adults with advanced cancer: The effects of rurality and education.

Xu H, Kadambi S, Mohile SG, Yang S, Kehoe LA, Wells M, Culakova E, Kamen C, Obrecht S, Mohamed M, Gilmore NJ, Magnuson A, Grossman VA, Hopkins JO, Geer J, Berenberg J, Mustian K, Cupertino A, Mohile N, Loh KP

Journal of geriatric oncology.. 2021 September 12 (7):1015-1021. Epub 04/12/2021.

Developing the Neurology Diversity Officer: A Roadmap for Academic Neurology Departments.

Mohile NA, Spector AR, Ebong IM, Flippen C, Gutierrez C, Leacock RO, Marulanda-Londoño E, Mejia NI, Thomas R, Hamilton RH

Neurology.. 2021 February 2296 (8):386-394. Epub 02/22/2021.

Meet the expert: How I treat chemotherapy-induced peripheral neuropathy.

Wasilewski A, Mohile N

Journal of geriatric oncology.. 2021 January 12 (1):1-5. Epub 06/17/2020.

Chemotherapy toxicities and geriatric syndromes in older patients with malignant gliomas.

Wasilewski A, Alam A, Mohile N

Journal of geriatric oncology.. 2021 January 12 (1):134-138. Epub 07/14/2020.

Review of the Role of the Brain in Chemotherapy-Induced Peripheral Neuropathy.

Omran M, Belcher EK, Mohile NA, Kesler SR, Janelsins MC, Hohmann AG, Kleckner IR

Frontiers in molecular biosciences.. 2021 8 :693133. Epub 06/11/2021.

Time to treatment initiation and outcomes in high-grade glioma patients in rehabilitation: a retrospective cohort study.

Warren KT, Liu L, Liu Y, Strawderman MS, Hussain AH, Ma HM, Milano MT, Mohile NA, Walter KA

CNS oncology.. 2020 December 19 (4):CNS64. Epub 10/28/2020.

Clinical Efficacy of Tumor Treating Fields for Newly Diagnosed Glioblastoma.

Liu Y, Strawderman MS, Warren KT, Richardson M, Serventi JN, Mohile NA, Milano MT, Walter KA

Anticancer research.. 2020 October 40 (10):5801-5806. Epub 1900 01 01.

Clinical neuro-oncology for the neurologist.

Lukas RV, Taylor JW, Kurz SC, Mohile NA

Neurology. Clinical practice.. 2020 October 10 (5):458-465. Epub 1900 01 01.

Disparities in patient enrollment on glioblastoma clinical trials.

Liu Y, Wasilewski A, Mohile NA

CNS oncology.. 2020 June 9 (2):CNS59. Epub 06/30/2020.

A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).

Cloughesy TF, Brenner A, de Groot JF, Butowski NA, Zach L, Campian JL, Ellingson BM, Freedman LS, Cohen YC, Lowenton-Spier N, Rachmilewitz Minei T, Fain Shmueli S, , Wen PY

Neuro-oncology.. 2020 May 1522 (5):705-717. Epub 1900 01 01.

Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic.

Mohile NA, Blakeley JO, Gatson NTN, Hottinger AF, Lassman AB, Ney DE, Olar A, Schiff D, Shih HA, Strowd R, van den Bent MJ, Ziu M

Neuro-oncology.. 2020 April 1122 (7):912-7. Epub 04/11/2020.

Epilepsy education in gliomas: engaging patients and caregivers to improve care.

Wasilewski A, Serventi J, Ibegbu C, Wychowski T, Burke J, Mohile N

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2020 March 28 (3):1405-1409. Epub 07/02/2019.

Top Ten Tips Palliative Care Clinicians Should Know When Caring for Patients with Brain Cancer.

Kluger BM, Ney DE, Bagley SJ, Mohile N, Taylor LP, Walbert T, Jones CA

Journal of palliative medicine.. 2020 March 23 (3):415-421. Epub 10/15/2019.

Occhiogrosso J, Hemminger L, Burke J, Ibegbu C, Serventi J, Mohile N

Journal of palliative medicine.. 2020 February 23 (2):264-267. Epub 07/30/2019.

The correlation of fractional anisotropy parameters with Ki-67 index, and the clinical implication in grading of non-enhancing gliomas and neuronal-glial tumors.

Liu X, Tian W, Kolar B, Johnson MD, Milano M, Jiang H, Lin S, Li D, Mohile NA, Li YM, Walter KA, Ekholm S, Wang H

Magnetic resonance imaging.. 2020 January 65 :129-135. Epub 10/20/2019.

Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study.

Gewandter JS, Chaudari J, Ibegbu C, Kitt R, Serventi J, Burke J, Culakova E, Kolb N, Sluka KA, Tejani MA, Mohile NA

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2019 May 27 (5):1765-1774. Epub 08/27/2018.

Response to Crevenna and Ashbury, Vallance and Bolam, and Crevenna and Keilani regarding the effects of exercise on chemotherapy-induced peripheral neuropathy.

Kleckner IR, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, Fung C, Janelsins MC, Asare M, Lin PJ, Reddy PS, Giguere J, Berenberg J, Kesler SR, Mustian KM

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2019 January 27 (1):7-8. Epub 10/29/2018.

Durable response to bevacizumab in adults with recurrent pilocytic astrocytoma.

Wasilewski A, Mohile N

CNS oncology.. 2018 July 17 (3):CNS26. Epub 04/09/2018.

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913.

Chinnaiyan P, Won M, Wen PY, Rojiani AM, Werner-Wasik M, Shih HA, Ashby LS, Michael Yu HH, Stieber VW, Malone SC, Fiveash JB, Mohile NA, Ahluwalia MS, Wendland MM, Stella PJ, Kee AY, Mehta MP

Neuro-oncology.. 2018 April 920 (5):666-673. Epub 1900 01 01.

Quality improvement in neurology: Neuro-oncology quality measurement set.

Jordan JT, Sanders AE, Armstrong T, Asher T, Bennett A, Dunbar E, Mohile N, Nghiemphu PL, Smith TR, Ney DE

Neurology.. 2018 April 390 (14):652-658. Epub 03/02/2018.

Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.

Kleckner IR, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, Fung C, Janelsins MC, Asare M, Lin PJ, Reddy PS, Giguere J, Berenberg J, Kesler SR, Mustian KM

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2018 April 26 (4):1019-1028. Epub 12/14/2017.

Quality improvement in neurology: Neuro-Oncology Quality Measurement Set.

Jordan JT, Sanders AE, Armstrong T, Asher T, Bennett A, Dunbar E, Mohile N, Nghiemphu PL, Smith TR, Ney DE

Neuro-oncology.. 2018 March 2720 (4):531-537. Epub 1900 01 01.

Medical Complications of Brain Tumors.

Mohile NA

Continuum : lifelong learning in neurology.. 2017 December 23 (6, Neuro-oncology):1635-1652. Epub 1900 01 01.

Acute care in glioblastoma: the burden and the consequences.

Wasilewski A, Serventi J, Kamalyan L, Wychowski T, Mohile N

Neuro-oncology practice.. 2017 December 4 (4):248-254. Epub 03/08/2017.

Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.

Thomas AA, Abrey LE, Terziev R, Raizer J, Martinez NL, Forsyth P, Paleologos N, Matasar M, Sauter CS, Moskowitz C, Nimer SD, DeAngelis LM, Kaley T, Grimm S, Louis DN, Cairncross JG, Panageas KS, Briggs S, Faivre G, Mohile NA, Mehta J, Jonsson P, Chakravarty D, Gao J, Schultz N, Brennan CW, Huse JT, Omuro A

Neuro-oncology.. 2017 October 119 (10):1380-1390. Epub 1900 01 01.

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.

Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH,

The Lancet. Oncology.. 2017 October 18 (10):1373-1385. Epub 08/23/2017.

Palliative and end-of-life care in glioblastoma: defining and measuring opportunities to improve care.

Hemminger LE, Pittman CA, Korones DN, Serventi JN, Ladwig S, Holloway RG, Mohile NA

Neuro-oncology practice.. 2017 September 4 (3):182-188. Epub 09/27/2016.

Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendations.

Gewandter JS, Freeman R, Kitt RA, Cavaletti G, Gauthier LR, McDermott MP, Mohile NA, Mohlie SG, Smith AG, Tejani MA, Turk DC, Dworkin RH

Neurology.. 2017 August 2289 (8):859-869. Epub 07/26/2017.

Painful chemotherapy-induced peripheral neuropathy: lack of treatment efficacy or the wrong clinical trial methodology?

Gewandter JS, Dworkin RH, Finnerup NB, Mohile NA

Pain.. 2017 January 158 (1):30-33. Epub 1900 01 01.

A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.

Trusheim J, Dunbar E, Battiste J, Iwamoto F, Mohile N, Damek D, Bota DA, Connelly J

CNS oncology.. 2017 January 6 (1):29-43. Epub 09/15/2016.

Reply.

Gewandter JS, Dworkin RH, Finnerup NB, Freeman R, Mohile NA

Pain.. 2017 January 158 (1):182-183. Epub 1900 01 01.

Survival of Secondary Central Nervous System Lymphoma Patients in the Rituximab Era.

Herr MM, Mohile NA, Barr PM, van Wijngaarden E, Brown EB, Rich DQ

Clinical lymphoma, myeloma & leukemia.. 2016 September 16 (9):e123-e127. Epub 06/08/2016.

Antidepressant use and risk of central nervous system metastasis.

Herr MM, Mohile NA, van Wijngaarden E, Brown EB, Rich DQ

Journal of neuro-oncology.. 2016 August 129 (1):179-87. Epub 06/11/2016.

Solving the riddle of glioblastoma: The hope for immunotherapy.

Bashir R, Mohile NA

Neurology.. 2016 June 1486 (24):2220-1. Epub 05/25/2016.

A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study.

Robins HI, Zhang P, Gilbert MR, Chakravarti A, de Groot JF, Grimm SA, Wang F, Lieberman FS, Krauze A, Trotti AM, Mohile N, Kee AY, Colman H, Cavaliere R, Kesari S, Chmura SJ, Mehta M

Journal of neuro-oncology.. 2016 January 126 (2):309-16. Epub 10/27/2015.

How I treat glioblastoma in older patients.

Mohile NA

Journal of geriatric oncology.. 2016 January 7 (1):1-6. Epub 12/22/2015.

Severe radiation-induced leukoencephalopathy:Case report and literature review

Cummings M; Dougherty D;Mohile N;Walter K;Usuki K; Milano M.

Advances in Radiation Oncology. 2016; 1: 17-20.

Palliative and end-of-life care in glioblastoma: defining and measuring opportunities to improve care

Lauryn E Hemminger; Christine A Pittman; David N Korones; Jennifer N Serventi; Susan Ladwig; Robert G Holloway; Nimish A Mohile.

Neuro-Oncology Practice. 2016; .

Planning TTFields treatment using the NovoTal system-clinical case series beyond the use of MRI contrast enhancement.

Connelly J; Hormigo A; Mohile, Hu J, Chaudhry A and Blondin N.

BMC Cancer. 2016; 16: 842.

Severe radiation-induced leukoencephalopathy: Case report and literature review.

Cummings M, Dougherty DW, Mohile NA, Walter KA, Usuki KY, Milano MT

Advances in radiation oncology.. 2016 1 (1):17-20. Epub 02/02/2016.

Advances in Primary Central Nervous System Lymphoma.

Patrick LB, Mohile NA

Current oncology reports.. 2015 December 17 (12):60. Epub 1900 01 01.

Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma.

Wen PY, Omuro A, Ahluwalia MS, Fathallah-Shaykh HM, Mohile N, Lager JJ, Laird AD, Tang J, Jiang J, Egile C, Cloughesy TF

Neuro-oncology.. 2015 September 17 (9):1275-83. Epub 05/26/2015.

Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population.

Ray S, Bonafede MM, Mohile NA

American health & drug benefits.. 2014 May 7 (3):140-9. Epub 1900 01 01.

Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of newer generation AEDs.

Wychowski T, Wang H, Buniak L, Henry JC, Mohile N

Clinical neurology and neurosurgery.. 2013 November 115 (11):2365-9. Epub 09/01/2013.

Diagnosis of primary CNS melanoma with neuroimaging.

Somers KE, Almast J, Biemiller RA, Silberstein HJ, Johnson MD, Mohile NA

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2013 January 131 (1):e9-11. Epub 11/19/2012.

Is brain the new bone marrow? Stem cells, cancer, and cognition: a working hypothesis.

Mohile NA, Zoccoli CM, Glantz M

Neurology.. 2011 March 2976 (13):1118-20. Epub 02/23/2011.

Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma.

Milano MT, Okunieff P, Donatello RS, Mohile NA, Sul J, Walter KA, Korones DN

International journal of radiation oncology, biology, physics.. 2010 November 1578 (4):1147-55. Epub 03/06/2010.

Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study.

Milano MT, Johnson MD, Sul J, Mohile NA, Korones DN, Okunieff P, Walter KA

Journal of neuro-oncology.. 2010 May 98 (1):83-92. Epub 11/07/2009.

Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.

Gutin PH, Iwamoto FM, Beal K, Mohile NA, Karimi S, Hou BL, Lymberis S, Yamada Y, Chang J, Abrey LE

International journal of radiation oncology, biology, physics.. 2009 September 175 (1):156-63. Epub 01/23/2009.

Utility of brain FDG-PET in primary CNS lymphoma.

Mohile NA, Deangelis LM, Abrey LE

Clinical advances in hematology & oncology : H&O.. 2008 November 6 (11):818-20, 840. Epub 1900 01 01.

A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis.

Mohile NA, Forsyth P, Stewart D, Raizer JJ, Paleologos N, Kewalramani T, Louis DN, Cairncross JG, Abrey LE

Journal of neuro-oncology.. 2008 September 89 (2):187-93. Epub 05/06/2008.

The utility of body FDG PET in staging primary central nervous system lymphoma.

Mohile NA, Deangelis LM, Abrey LE

Neuro-oncology.. 2008 April 10 (2):223-8. Epub 02/20/2008.

Primary central nervous system lymphoma.

Mohile NA, Abrey LE

Neurologic clinics.. 2007 November 25 (4):1193-207, xi. Epub 1900 01 01.

Primary central nervous system lymphoma.

Mohile NA, Abrey LE

Seminars in radiation oncology.. 2007 July 17 (3):223-9. Epub 1900 01 01.

T-cell lymphoma presenting with neurologic features in immunocompetent children.

Bassuk AG, Mohile NA, Stack C

Pediatric neurology.. 2006 November 35 (5):314-7. Epub 1900 01 01.

Books

Brain Tumors: Practical Guide to Diagnosis and Treatment (2007)

Chapter: Principles of Chemotherapy

Authors: Abrey LE and Mohile NA

Publisher: Informa Health Care, USA, New York 2007

Handbook of Brain Tumor Chemotherapy (2006)

Chapter: Chemotherapy of Neuronal Tumors

Authors: Mohile, N.A.; Raizer, J.J.

Publisher: Elsevier, Amsterdam: Boston 2006

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

During this visit, did this provider spend enough time with you?

4.6

During this visit, did this provider show respect for what you had to say?

4.9

During this visit did this provider give you easy to understand information about these health questions or concerns?

4.7

During this visit, did this provider listen carefully to you?

4.8

During this visit, did this provider explain things in a way that was easy to understand?

4.8

Patient Comments

5.0

Excellent experience, kind caring. Gave us the time to explain condition and gave us options

Feb 24, 2024

DR. MOHILE AND HIS STAFF ARE THE BEST

Nov 03, 2023

5.0

Dr. Mohile and Jennifer Serventi are awesome. We are so happy and blessed to have them as [...] provider.

Nov 01, 2023

3.8

Doctor seemed to be in a rush to finish the appointment. [...]

Sep 22, 2023

[...] Dr. Mohile answered my questions and he will reach out after reviewing my image if there are impressions he would like to discuss.

Aug 11, 2023

1.0

Provider was polite and formal. He did have something difficult to explain that was not good news, but he was not empathetic. He left after telling me to sit in the visit room I was in and compose myself before leaving.

Apr 20, 2023

5.0

Great crew of oncology care

Mar 18, 2023

5.0

All options discussed, always asked if more questions needed for understanding.

Jan 26, 2023

Dr. Mohile's expertise brings me comfort in my care plan. I appreciate Dr. Mohile's flexibility with scheduling online and that he'd see me in person if that were my perference.

Nov 22, 2022

5.0

Mohile is a great doctor

Nov 03, 2022

5.0

The MD is excellent. [...]

Sep 01, 2022